Home > Financial Ratios > LACTOSE (INDIA)

LACTOSE (INDIA)
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for LACTOSE (INDIA)
Please provide your vote to see the results

LACTOSE (INDIA) Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 66.33-5.7996.48-31.65-4.68

What is the latest Core EBITDA Growth ratio of LACTOSE (INDIA) ?

The latest Core EBITDA Growth ratio of LACTOSE (INDIA) is 66.33 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar202466.33
Mar2023-5.79
Mar202296.48
Mar2021-31.65
Mar2020-4.68

How is Core EBITDA Growth of LACTOSE (INDIA) Trending?

Years Core EBITDA Growth % Change
Mar2024 66.33
Positive
Mar2023 -5.79
Negative
Mar2022 96.48
Positive
Mar2021 -31.65
Negative
Mar2020 -4.68 -

Other Financial Ratios of LACTOSE (INDIA)


Compare Core EBITDA Growth ratio of peers of LACTOSE (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LACTOSE (INDIA) ₹145.0 Cr 0.6% -9.2% -30% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,626.0 Cr 1.2% 4.4% -9.7% Stock Analytics
DIVIS LABORATORIES ₹180,669.0 Cr 5.8% 19.2% 16.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,793.0 Cr 1.4% 1.8% 10.8% Stock Analytics
CIPLA ₹122,103.0 Cr -3.7% -0.2% 1.6% Stock Analytics
DR REDDYS LABORATORIES ₹99,857.4 Cr -7.3% -4% -6.1% Stock Analytics


LACTOSE (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LACTOSE (INDIA)

0.6%

-9.2%

-30%

SENSEX

-0.9%

4.6%

5%


You may also like the below Video Courses